BCPCNasdaqChemicals & Allied ProductsFiscal year ends December 31
BALCHEM CORP
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Oct 23, 2026
$170.42−0.31 (-0.18%)
Close on Oct 19, 2026
- Market cap
- $5.49B
- P/E (TTM)
- 33.5
- Dividend yield
- 0.56%
BALCHEM CORP revenue by segment
By business segment
| Revenue | TTM Q2 26 | TTM Q1 26 | TTM Q4 25 | TTM Q3 25 | TTM Q2 25 | TTM Q1 25 | TTM Q4 24 | TTM Q3 24 | TTM Q2 24 | TTM Q1 24 | TTM Q4 23 | TTM Q3 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Human Nutrition and Health | $688.68M | $672.56M | $659.39M | $640.62M | $618.82M | $605.97M | $600.26M | $590.93M | $583.10M | $570.84M | $550.75M | $543.18M | 63.4% | +11.3% |
| Animal Nutrition and Health | $244.19M | $235.76M | $230.85M | $228.01M | $224.54M | $218.07M | $214.71M | $214.55M | $215.59M | $227.36M | $238.33M | $244.91M | 22.5% | +8.8% |
| Specialty Products | $145.75M | $142.43M | $140.98M | $138.99M | $136.50M | $134.41M | $132.75M | $130.90M | $127.72M | $125.35M | $125.97M | $126.78M | 13.4% | +6.8% |
| Operating income | TTM Q2 26 | TTM Q1 26 | TTM Q4 25 | TTM Q3 25 | TTM Q2 25 | TTM Q1 25 | TTM Q4 24 | TTM Q3 24 | TTM Q2 24 | TTM Q1 24 | TTM Q4 23 | TTM Q3 23 | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Human Nutrition and Health | $159.99M | $155.95M | $153.91M | $150.90M | $145.65M | $140.67M | $135.96M | – | – | – | – | – | +9.8% |
| Specialty Products | $46.88M | $45.25M | $42.90M | $42.35M | $41.33M | $41.29M | $39.91M | – | – | – | – | – | +13.4% |
| Animal Nutrition and Health | $20.86M | $19.14M | $18.69M | $18.19M | $18.01M | $17.19M | $14.01M | – | – | – | – | – | +15.8% |
By product or service
| Revenue | TTM Q2 26 | TTM Q1 26 | TTM Q4 25 | TTM Q3 25 | TTM Q2 25 | TTM Q1 25 | TTM Q4 24 | TTM Q3 24 | TTM Q2 24 | TTM Q1 24 | TTM Q4 23 | TTM Q3 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Product Sales Revenue | $1.08B | $1.06B | $1.04B | $1.01B | $984.20M | $962.88M | $951.95M | $940.82M | $930.57M | $927.32M | $919.95M | $953.54M | 99.8% | +10.1% |
| Royalty Revenue | $2.13M | $1.92M | $1.89M | $1.80M | $1.73M | $1.66M | $1.74M | $1.56M | $1.82M | $2.24M | $2.49M | $3.03M | 0.2% | +23.0% |
| Consignment | – | – | – | – | – | – | – | – | – | – | – | $9.46M | – | – |
| Co-manufacturing | – | – | – | – | – | – | – | – | – | – | – | $35.82M | – | – |
| Product Sales Revenue | – | – | – | – | – | – | – | – | – | – | – | $923.24M | – | – |
By region
| Revenue | TTM Q2 26 | TTM Q1 26 | TTM Q4 25 | TTM Q3 25 | TTM Q2 25 | TTM Q1 25 | TTM Q4 24 | TTM Q3 24 | TTM Q2 24 | TTM Q1 24 | TTM Q4 23 | TTM Q3 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| United States | $789.60M | $771.11M | $759.45M | $752.02M | $735.95M | $726.94M | $723.30M | $716.27M | $711.05M | $704.80M | $689.60M | $679.21M | 72.7% | +7.3% |
| Foreign Countries | $296.29M | $286.24M | $277.71M | $261.52M | $249.98M | $237.61M | $230.38M | $226.11M | $221.34M | $224.76M | $232.84M | $247.07M | 27.3% | +18.5% |
From the segment and revenue-disaggregation notes of Balchem's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.